Belgium· BE-AMP-SAM300833-00
Reparil 1 %
A preparations with salicylic acid derivatives product containing diethylamine salicylate, registered in Belgium by Cooper Consumer Health. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Diethylamine salicylate is registered in 8 of 19 countries.
Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Diethylamine salicylate · ATC M02AC
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Diethylamine Salicylate
- Manufacturer
- Cooper Consumer Health
- Country
- Belgium (BE)
- ATC code
- M02AC
- ATC class
- Preparations with salicylic acid derivatives
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2396083
- be_apb2396091
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Diethylamine salicylate in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Algofina
- United Kingdom (Northern Ireland) · Algesal, Odour Free Lloyds
- Hungary · Aciphen
- Portugal · Medalginan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/217f5e84-1cf9-4c90-b6fa-57c844bcfe63 GET /v1/drugs/217f5e84-1cf9-4c90-b6fa-57c844bcfe63?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Gel",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Reparil 1 %",
"name_fr": "Reparil 1 %",
"name_nl": "Reparil 1 %",
"amp_code": "SAM300833-00",
"strengths": [
"5.0000",
"5.0000",
"5.0000",
"1.0000",
"1.0000",
"1.0000",
"0.0100"
],
"pack_count": 6,
"substances": [
"Diethylamine Salicylate",
"Escin",
"Sodium Edetate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Preparations with Salicylic Acid Derivatives",
"authorisation_numbers": [
"BE300833"
]
}See everything about diethylamine salicylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.